Literature DB >> 2402410

Autologous nasal mucosa transplantation in severe bilateral conjunctival mucus deficiency syndrome.

G O Naumann1, G K Lang, V Rummelt, M E Wigand.   

Abstract

From 1984 to 1989, 24 patients with desperate ocular surface wetting problems due to mucus deficiency syndrome with extensive symblephara or lid fusion were treated by autologous free transplants of nasal mucosa from the nasal conchae. This procedure covers the ocular surface not only with nonkeratinizing epithelium but also with goblet cells and produces a mucus layer. This was proven by biopsy in three patients after 1 to 3 years. In all of the patients, conjunctival transplants were not available. Pronounced relief of pain and modest visual improvements are achieved with this procedure, and free autologous nasal mucosal grafts appear to be superior to buccal mucosa in reestablishing the anterior ocular surface. The authors recommend the technique for all patients with massive and otherwise intractable symblephara following lye burns.

Entities:  

Mesh:

Year:  1990        PMID: 2402410     DOI: 10.1016/s0161-6420(90)32471-5

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  11 in total

1.  Long term results after autologous nasal mucosal transplantation in severe mucus deficiency syndromes.

Authors:  H Wenkel; V Rummelt; G O Naumann
Journal:  Br J Ophthalmol       Date:  2000-03       Impact factor: 4.638

2.  [Late complications after chemical burns of the ocular surface. Surgical strategies for ocular surface reconstruction].

Authors:  B Bachmann; C Cursiefen
Journal:  Ophthalmologe       Date:  2011-10       Impact factor: 1.059

3.  Cultured corneal epithelia for ocular surface disease.

Authors:  I R Schwab
Journal:  Trans Am Ophthalmol Soc       Date:  1999

4.  [Squamous cell carcinoma of the conjunctiva with orbital invasion: orbital exenteration or minimally invasive procedure?].

Authors:  J Beutel; K Sommer; S Gottschalk; B Neppert; G Geerling
Journal:  Ophthalmologe       Date:  2006-08       Impact factor: 1.059

5.  Ocular surface reconstruction with a tissue-engineered nasal mucosal epithelial cell sheet for the treatment of severe ocular surface diseases.

Authors:  Masakazu Kobayashi; Takahiro Nakamura; Makoto Yasuda; Yuiko Hata; Shoki Okura; Miyu Iwamoto; Maho Nagata; Nigel J Fullwood; Noriko Koizumi; Yasuo Hisa; Shigeru Kinoshita
Journal:  Stem Cells Transl Med       Date:  2014-11-19       Impact factor: 6.940

6.  Transplantation of amniotic membrane and limbal autograft for patients with recurrent pterygium associated with symblepharon.

Authors:  J Shimazaki; N Shinozaki; K Tsubota
Journal:  Br J Ophthalmol       Date:  1998-03       Impact factor: 4.638

7.  Follow up of patients with ocular scarring secondary to LOC syndrome treated by amniotic membrane transplantation.

Authors:  J E Moore; S Shah; V Kumar; J R Ainsworth; A B Page; W H I McLean
Journal:  Br J Ophthalmol       Date:  2005-08       Impact factor: 4.638

Review 8.  Current and Upcoming Therapies for Ocular Surface Chemical Injuries.

Authors:  Alireza Baradaran-Rafii; Medi Eslani; Zeeshan Haq; Ebrahim Shirzadeh; Michael J Huvard; Ali R Djalilian
Journal:  Ocul Surf       Date:  2016-09-17       Impact factor: 5.033

9.  Surgical management of ocular surface disorders using conjunctival and stem cell allografts.

Authors:  D J Coster; R K Aggarwal; K A Williams
Journal:  Br J Ophthalmol       Date:  1995-11       Impact factor: 4.638

Review 10.  Current concepts of ocular adnexal surgery.

Authors:  Maria Borrelli; Gerd Geerling
Journal:  GMS Interdiscip Plast Reconstr Surg DGPW       Date:  2013-02-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.